Products for Research Use Only
RegisterLogin

Cilofexor

CAT: 0013-GTR19163272-02Size: 2 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19163272-02Size:2 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cilofexor (GS-9674, GS9674, PX-104) is a novel specific, non-steroidal farnesoid X receptor (FXR) agonist that reduces liver fibrosis and ameliorates portal hypertension in rat NASH models.Steatohepatitis, Phase 2 Clinical (In Vivo) :Cilofexor (GS-9674; 30 mg/kg; oral gavage; once daily; for 10 weeks; male Wistar rats) treatment significantly increases Fgf15 expression in the ileum and decreased Cyp7a1 in the liver in nonalcoholic steatohepatitis (NASH) rats. Liver fibrosis and hepatic collagen expression are significantly reduced. Cilofexor also significantly reduces hepatic stellate cell (HSC) activation and significantly decreases portal pressure, without affecting systemic hemodynamics.
CAS Number
1418274-28-8
Product Name Alternative
GS-9674 | GS9674 | PX-104
Purity
>98% (HPLC)
Solubility
DMSO : 125 mg/mL213.00 mM; H2O : < 0.1 mg/mL
Smiles
OC (C1=CC=NC (N2CC (O) (C2) C3=C (C=C (C=C3) OCC4=C (ON=C4C5=C (C=CC=C5Cl) Cl) C6CC6) Cl) =C1) =O
Molecular Formula
C28H22Cl3N3O5
Molecular Weight
586.85
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2-[3-[2-Chloro-4-[[5-cyclopropyl-3- (2,6-dichlorophenyl) -4-isoxazolyl]methoxy]phenyl]-3-hydroxy-1-azetidinyl]-4-pyridinecarboxylic acid

Chemical Information

Cilofexor

Cilofexor is under investigation in clinical trial NCT02943447 (Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis).

CAS Number1418274-28-8
PubChem CID71228883
IUPAC Name2-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxyazetidin-1-yl]pyridine-4-carboxylic acid
Molecular FormulaC28H22Cl3N3O5
Molecular Weight586.8
XLogP5.3
Topological Polar Surface Area109
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count8
Heavy Atom Count39
Formal Charge0
Complexity867
SMILES
C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC(=C(C=C4)C5(CN(C5)C6=NC=CC(=C6)C(=O)O)O)Cl
InChI
InChI=1S/C28H22Cl3N3O5/c29-20-2-1-3-21(30)24(20)25-18(26(39-33-25)15-4-5-15)12-38-17-6-7-19(22(31)11-17)28(37)13-34(14-28)23-10-16(27(35)36)8-9-32-23/h1-3,6-11,15,37H,4-5,12-14H2,(H,35,36)
InChIKey
KZSKGLFYQAYZCO-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Cilofexor
CAS: 1418274-28-8
CID: 71228883
Formula: C28H22Cl3N3O5
MW: 586.8
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight586.8
XLogP35.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count8
Exact Mass585.062504
Monoisotopic Mass585.062504
Topological Polar Surface Area109 Ų
Heavy Atom Count39
Formal Charge0
Complexity867
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products

CatalogName
BA3598-1Cilofexor
A13143-50Cilofexor 50mg
A13143-5Cilofexor 5mg
A13143-2Cilofexor 2mg
T69724-01Cilofexor tromethamine
A13143-25Cilofexor 25mg
HY-109083ACilofexor (tromethamine)
A13143-500Cilofexor 500mg
A13143-100Cilofexor 100mg
A13143-10Cilofexor 10mg

Popular Products